Outcomes of Patients with Acute Pulmonary Embolism Managed with Catheter-Based Therapies as Compared to Medical Therapy at 3-6 Months Follow-Up

被引：0
|
作者：
Kong, N. [1 ]
Acosta, M. [1 ]
Zahid, A. [1 ]
Clarke, M. [1 ]
Teerapuncharoen, K. [2 ]
Bag, R. [2 ]
Paul, J. [3 ]
机构：
[1] Univ Chicago, Dept Internal Med, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Internal Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Internal Med, Sect Cardiol, Chicago, IL 60637 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5425
引用
收藏
页数：2
相关论文
共 34 条
  • [21] Cell Therapy in Patients with Advanced Chronic Obstructive Pulmonary Disease: 3 and 6 months follow up of Six Minute Walk Test, Quality of life and Pulmonary Function
    Squassoni, Selma D.
    Fiss, Elie
    Lapa, Monica S.
    Sekiya, Eliseo J.
    Alves, Adelson
    Forte, Andresa
    Machado, Nadine C.
    Ribeiro-Paes, Joao T.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [22] Respiratory Outcomes in COVID-19 patients 3-6 months after admission to Public Health Hospital Maciel. Montevideo, Uruguay. A Follow up Cohort Study
    Nunez, M. J.
    Mamchur, M.
    Chao, C.
    Rodriguez Flores, C.
    Pacheco, E.
    Tempone, A.
    Rabunal, K.
    Silva, C.
    Gimenez, F.
    Gruss, A. I.
    Acosta, C.
    Iraola, V.
    Lopez Varela, M. V.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Early responses to 3 mm resilient stabilization appliance therapy for sub-acute and chronic temporomandibular disorder pain predict 12-months follow-up outcomes
    Emshoff, Ruediger
    Bertram, Annika
    Stigler, Robert Gerhard
    Schnabl, Dagmar
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2022, 40 (01): : 72 - 78
  • [24] A comparison of quality of life scores in patients with stable angina pectoris after medical treatment compared with angioplasty or coronary bypass surgery: 48-months of follow-up outcomes of a randomized clinical trial (MASS II)
    Takiuti, ME
    Nogueira, CR
    Girardi, P
    Nakano, T
    Palomo, J
    Lopes, N
    Hueb, W
    Ramires, JAF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 262A - 262A
  • [25] Pulmonary Function, CT Features and 6-Minute Walk Test at 3-Months in Severe COVID-19 Patients Treated with Intravenous Pulsed Methylprednisolone: A Follow-Up Study
    Van Zeller, C.
    Anwar, A.
    Bascon, N.
    Barnes, N.
    Madden, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [26] Bleeding outcomes in low-mediate risk acute coronary syndrome patients receiving stenting predicted by adenosine diphophate induced platelet aggregation after initiation of clopidogrel: 6 months follow-up
    Cui Tongtao
    Yu, Huimin
    Dong, Taiming
    Zhang, Bin
    Yan, Hong
    Wu, Handong
    Liao, Hongtao
    Jin, Lijun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C126 - C126
  • [27] Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: A Danish, population-based, 6-year follow-up study
    Lohse, N
    Kronborg, G
    Gerstoft, J
    Larsen, CS
    Pedersen, G
    Pedersen, C
    Sorensen, HT
    Obel, N
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (01) : 136 - 144
  • [28] A randomized trial of medical care with and without physical therapy and chiropractic care with and without physical modalities for patients with low back pain: 6-month follow-up outcomes from the UCLA low back pain study
    Hurwitz, EL
    Morgenstern, H
    Harber, P
    Kominski, GF
    Belin, TR
    Yu, F
    Adams, AH
    SPINE, 2002, 27 (20) : 2193 - 2204
  • [29] The level of residual CLL at assessment of response and in follow-up objectively predicts the outcome of patients following FCR-based therapy: >1% residual disease in the marrow 3 months post-treatment predicts early relapse and poor survival
    Rawstron, Andy
    Cohen, Dena
    de Tute, Ruth
    McParland, Lucy
    Collett, Laura
    Phillips, David
    Chalmers, Anna
    Varghese, Abraham
    Munir, Talha
    Gregory, Walter
    Hillmen, Peter
    LEUKEMIA & LYMPHOMA, 2015, 56 : 129 - 130
  • [30] Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients With Steroid-refractory Acute GRAFT-VS-HOST Disease (SR-AGVHD): 6-Month Follow-up From The Randomized, Phase 3 Reach2 Study
    Mohty, Mohamad
    Bulabois, Claude-Eric
    Garcia-Gutierrez, Valentin
    Ritchie, David
    Yoon, Sung-Soo
    Coiteux, Valerie
    Kwong, Yok-Lam
    Niederwieser, Dietger
    Or, Reuven
    Socie, Gerard
    von Bubnoff, Nikolas
    Zeiser, Robert
    Xu, Judith
    Morando, Juliane
    Mahuzier, Bruyere
    Szer, Jeff
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 80 - 82
1234